Navigation Links
Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
Date:4/30/2012

Blacksburg, Va., May 1, 2012 - Virginia Tech released today the results of its 2012 rating for adult football helmets that is designed to assess a helmet's ability to reduce the risk of concussion. A total of three helmets achieved a "5 star" mark, which is the highest rating awarded by the Virginia Tech Helmet Ratings. In addition to the Riddell Revolution Speed, which was the only helmet to receive 5 stars last year, the Rawlings Quantum Plus and Riddell 360 also earned 5 stars as the best available helmets.

The process used for evaluating the head protector involves performing 120 impacts on each helmet model at multiple locations and impact energies. To date, the Virginia Tech Helmet Ratings for adult football include 15 helmet models that were evaluated using more than 2000 laboratory tests. The ratings, first introduced in 2011, utilize the STAR Evaluation System to assess helmet performance. The STAR, an acronym for the Summation of Tests for the Analysis of Risk, evaluation system was developed using data collected from over 1.8 million head impacts experienced by football players throughout an eight-year span.

"This is a perfect example of a National Institutes of Health (NIH) funded project resulting in translational research. The NIH supported the development of the sensors and data collection that provided the foundation for our rating system. Specifically, you can see Riddell and Rawlings using this research to develop the very best helmets," said project director Stefan Duma, the Harry C. Wyatt Professor and Department Head of the Virginia Tech Wake Forest School of Biomedical Engineering and Sciences (SBES).

A total of five new adult football helmet models by Rawlings, Riddell, and Xenith have been released since the Virginia Tech Helmet Ratings were first made available in 2011. The Riddell 360 (5 stars), Rawlings Quantum Plus (5-stars), Rawlings Impulse (4-
'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study
2. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
3. Virginia Tech graduate student receives first Rachel Carson award for scientific excellence
4. Nine Additional Virginia Law Enforcement Agencies Deploy BIO-key(R) and DaPro Systems Solution
5. Virginia Tech biomedical engineering team to study knee ligament sprains
6. Advances in cancer detection research by Virginia Tech engineer featured in British magazine
7. Virginia Tech licenses GenoCAD source code to ISCB
8. Guggenheim fellowship supports research on evolution by Virginia Tech scientist
9. Student research team sequences genome of bacterium discovered in Virginia Tech garden
10. Northrop Grumman Selects Virginia for New Corporate Office
11. Virginia Tech researcher explores role of human behavior in infectious disease emergence
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
(Date:7/13/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... method to make payments.  With this patent, NXT-ID ... its groundbreaking voice-direct payment patent application, with behavior-directed ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/7/2015)... MOUNTAIN VIEW, Calif. , July 7, 2015 ... mobile biometrics market, Frost & Sullivan recognizes Credence ... & Sullivan Entrepreneurial Company of the Year ... product suite to aid in its mission of ... and under-recognized populations globally. As Credence ID was ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... awash in electrical activity, and not just from the ... In fact, the brain is enveloped in countless overlapping ... of communicating neurons. The fields were once thought to ... neural communication," says neuroscientist Costas Anastassiou, a postdoctoral scholar ...
... release is available in French . ... growing problem in hospitals and other health care facilities, but ... in several decades. However, a large-scale, phase 3 trial conducted ... Fidaxomicin is superior to existing treatments, demonstrating a 45 percent ...
... Sputnik moment," President Obama emphasized the national need for ... State of the Union address last week: "We,ll invest ... technologyan investment that will strengthen our security, protect our ... President Obama specifically cited the need for research ...
Cached Biology News:Neurobiologists find that weak electrical fields in the brain help neurons fire together 2Neurobiologists find that weak electrical fields in the brain help neurons fire together 3First new C. difficile drug in a generation superior to existing treatments: Researchers 2
(Date:7/30/2015)... MN (PRWEB) , ... July 31, 2015 , ... Ralco ... Enrichment Center at the Lyon County Fair to be held August 5-9 in Marshall. ... about where their meals come from and how agriculture impacts their daily lives. This ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/29/2015)... , July 30, 2015 ... results for the second quarter of 2015. CEO ... results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered ... results - Performance drivers ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Focus on ... Supportive ... Companies, Inc. (NYSE: PRX ) today announced its commitment,to ... of Strativa Pharmaceuticals, its proprietary,specialty pharmaceuticals division. Strativa Pharmaceuticals will ...
... Idenix,Pharmaceuticals, Inc. (Nasdaq: IDIX ), a ... of drugs for the treatment of human ... part of the,restructuring, Idenix has amended the ... Tyzeka(R)/Sebivo(R). Per the amended agreement, Idenix,will discontinue ...
... Settlement, NORCROSS, Ga., Sept. 28 ... leader in providing automated instrument-reagent,systems to the ... and Exchange Commission (SEC) has agreed to ... certain,activities involving the company,s Italian subsidiary. ...
Cached Biology Technology:Introducing Strativa Pharmaceuticals 2Introducing Strativa Pharmaceuticals 3Introducing Strativa Pharmaceuticals 4Introducing Strativa Pharmaceuticals 5Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 4Immucor Settles SEC Investigation 2
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
... VIP (6-28) (human, bovine, porcine, ... Peptide (VIP) receptor antagonist. This ... to be twofold more potent ... receptor antagonists. ...
... Invitrogens EvoQuest Services are uniquely ... in the current competitive environment. ... techniques to express, purify, and ... needs: Structure/Function Studies, Activity Assays, ...
Request Info...
Biology Products: